The Role of Mitochondrial Dysfunction-Mediated Changes in Immune Cytokine Expression in the Pathophysiology and Treatment of Major Depressive Disorder

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Molecular Neurobiology

• Publication date

  2025-03-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12035-025-04872-yPMID 40163267
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuroprotective effects of probiotics on anxiety- and depression-like disorders in stressed mice by modulating tryptophan metabolism and the gut microbiota.

  2024cited by this paper
• Mitochondria of Intestinal Epithelial Cells in Depression: Are They at A Crossroads of Gut-brain Communication?

  2023cited by this paper
• The role of endoplasmic reticulum stress, mitochondrial dysfunction and their crosstalk in intervertebral disc degeneration.

  2023influential reference
• Neuroinflammation, Microbiota-Gut-Brain Axis, and Depression: The Vicious Circle.

  2023cited by this paper
• Yamogenin Exhibits Antidepressant-like Effects via Inhibition of ER Stress and Microglial Activation in LPS-Induced Mice.

  2023cited by this paper
• Dysfunctional mitochondrial processes contribute to energy perturbations in the brain and neuropsychiatric symptoms

  2023cited by this paper
• The Brain-Gut-Microbiota Interplay in Depression: a key to design innovative therapeutic approaches.

  2023cited by this paper
• Gut microbiota and its metabolites in depression: from pathogenesis to treatment

  2023cited by this paper
• The Role of Gut Dysbiosis in the Pathophysiology of Neuropsychiatric Disorders

  2022cited by this paper
• C-Reactive Protein as a Biomarker for Major Depressive Disorder?

  2022cited by this paper
• The FXR mediated anti-depression effect of CDCA underpinned its therapeutic potentiation for MDD.

  2022cited by this paper
• Inflammation, Lifestyle Factors, and the Microbiome‐Gut‐Brain Axis: Relevance to Depression and Antidepressant Action

  2022cited by this paper
• The mitochondrial associated endoplasmic reticulum membranes: A platform for the pathogenesis of inflammation‐mediated metabolic diseases

  2022cited by this paper
• Stress Reduces Extracellular ATP in the Prefrontal Cortex and Activates the Prefrontal Cortex-Lateral Habenula Pathway for Depressive-like Behavior.

  2022cited by this paper
• Neuroprotective Natural Products’ Regulatory Effects on Depression via Gut–Brain Axis Targeting Tryptophan

  2022cited by this paper
• Inflammation-Related Changes in Mood Disorders and the Immunomodulatory Role of Lithium

  2021cited by this paper
• Nuclear receptors modulate inflammasomes in the pathophysiology and treatment of major depressive disorder

  2021cited by this paper
• Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with Major Depressive Disorder.

  2021cited by this paper
• Mitophagy in depression: pathophysiology and treatment targets.

  2021cited by this paper
• Ganoderic acid A exerted antidepressant-like action through FXR modulated NLRP3 inflammasome and synaptic activity.

  2021cited by this paper
• The Role of Unfolded Protein Response in Human Intervertebral Disc Degeneration: Perk and IRE1-α as Two Potential Therapeutic Targets

  2021cited by this paper
• Ganoderic Acid A Attenuates LPS-Induced Neuroinflammation in BV2 Microglia by Activating Farnesoid X Receptor

  2021cited by this paper
• Mitochondrial-Targeting Therapeutic Strategies In The Treatment Of Depression.

  2021cited by this paper
• Differential protection by anthocyanin-rich bilberry extract and resveratrol against lipid micelle-induced oxidative stress and monolayer permeability in Caco-2 intestinal epithelial cells.

  2021cited by this paper
• Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain

  2021cited by this paper
• Neuroinflammation in psychiatric disorders: PET imaging and promising new targets.

  2020cited by this paper
• Mitochondrial Dysfunction as a Critical Event in the Pathophysiology of Bipolar Disorder.

  2020cited by this paper
• Bag‐1 mediates glucocorticoid receptor trafficking to mitochondria after corticosterone stimulation: Potential role in regulating affective resilience

  2020cited by this paper
• Molecular correlates of mitochondrial dysfunctions in major depression: evidence from clinical and rodent studies.

  2020cited by this paper
• The role of the endoplasmic reticulum stress in depression.

  2020cited by this paper
• Depression, mitochondrial bioenergetics, and electroconvulsive therapy: a new approach towards personalized medicine in psychiatric treatment - a short review and current perspective

  2020cited by this paper
• Oridonin is an antidepressant molecule working through the PPAR-γ/AMPA receptor signaling pathway.

  2020cited by this paper
• Effects of Probiotics on Depressive or Anxiety Variables in Healthy Participants Under Stress Conditions or With a Depressive or Anxiety Diagnosis: A Meta-Analysis of Randomized Controlled Trials

  2020cited by this paper
• Impaired ATP Release from Brain Astrocytes May be a Cause of Major Depression

  2020cited by this paper
• Novel Neuroimmunologic Therapeutics in Depression: A Clinical Perspective on What We Know So Far.

  2020cited by this paper
• Severe life stress, mitochondrial dysfunction, and depressive behavior: A pathophysiological and therapeutic perspective.

  2020cited by this paper
• Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders

  2020cited by this paper
• Role of Inflammation in Depression and Treatment Implications.

  2019cited by this paper
• Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders

  2019cited by this paper
• Systematic Review of Gut Microbiota and Major Depression

  2019cited by this paper
• Coenzyme Q10 Alleviated Behavioral Dysfunction and Bioenergetic Function in an Animal Model of Depression

  2019cited by this paper
• Mitochondrial Involvement in Mental Disorders: Energy Metabolism and Genetic and Environmental Factors.

  2019cited by this paper
• Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw

  2019cited by this paper
• Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain.

  2019cited by this paper
• Gut microbiota–brain axis in depression: The role of neuroinflammation

  2019cited by this paper
• Role of endoplasmic reticulum stress in depression

  2019cited by this paper
• Coenzyme Q 10 Alleviated Behavioral Dysfunction and Bioenergetic Function in an Animal Model of Depression

  2019cited by this paper
• The effect of fluoxetine on astrocyte autophagy flux and injured mitochondria clearance in a mouse model of depression

  2019cited by this paper
• Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.

  2019cited by this paper
• The role of mitochondria in NLRP3 inflammasome activation.

  2018cited by this paper
• Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression

  2018cited by this paper
• Neutrophil-lymphocyte Ratio and C-reactive Protein Level in Patients with Major Depressive Disorder Before and After Pharmacotherapy.

  2018cited by this paper
• Immune-based strategies for mood disorders: facts and challenges

  2018cited by this paper
• Blood-based biomarkers predicting response to antidepressants

  2018cited by this paper
• The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression.

  2018cited by this paper
• The effects of adiposity and alcohol use disorder on adipokines and biomarkers of inflammation in depressed patients.

  2018cited by this paper
• Microglia Polarization and Endoplasmic Reticulum Stress in Chronic Social Defeat Stress Induced Depression Mouse

  2018cited by this paper
• Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies

  2017cited by this paper
• Shared metabolic and immune‐inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders

  2017cited by this paper
• Effects of gut microbiota disturbance induced in early life on the expression of extrasynaptic GABA-A receptor α5 and δ subunits in the hippocampus of adult rats.

  2017cited by this paper
• Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.

  2017cited by this paper
• Pro-inflammatory Cytokines, Biomarkers, Genetics and the Immune System: A Mechanistic Approach of Depression and Psoriasis.

  2017cited by this paper
• Stress & the gut-brain axis: Regulation by the microbiome

  2017cited by this paper
• What Can Mitochondrial DNA Analysis Tell Us About Mood Disorders?

  2017cited by this paper
• Stress-induced anhedonia is associated with the activation of the inflammatory system in the rat brain: Restorative effect of pharmacological intervention.

  2016cited by this paper
• Mitochondrial Dysfunction in Depression

  2016cited by this paper
• Evidence for Inflammation-Associated Depression.

  2016cited by this paper
• Innate and adaptive immunity in the development of depression: An update on current knowledge and technological advances

  2016cited by this paper
• α5GABAA receptor deficiency causes autism‐like behaviors

  2016cited by this paper
• Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases

  2015cited by this paper
• Inflammation: depression fans the flames and feasts on the heat.

  2015cited by this paper
• Mitochondrial Mutations in Subjects with Psychiatric Disorders

  2015cited by this paper
• Advances in biomarkers of major depressive disorder.

  2015cited by this paper
• The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders

  2015cited by this paper
• Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition

  2015cited by this paper
• Biomarker approaches in major depressive disorder evaluated in the context of current hypotheses.

  2015cited by this paper
• A mitochondrial bioenergetic basis of depression

  2015cited by this paper
• Biomarkers of psychiatric diseases: current status and future prospects.

  2015cited by this paper
• Mitochondria and the central nervous system: searching for a pathophysiological basis of psychiatric disorders.

  2014influential reference
• Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress

  2014cited by this paper
• The association between depressive symptoms, cognitive function, and inflammation in major depression.

  2014cited by this paper
• A review of the relationship between proinflammatory cytokines and major depressive disorder.

  2014cited by this paper
• Calcium signaling and mitochondrial destabilization in the triggering of the NLRP3 inflammasome.

  2014cited by this paper
• Perfusion deficits, inflammation and aging precipitate depressive behaviour

  2014cited by this paper
• A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers.

  2014cited by this paper
• Role of inflammation in depression: implications for phenomenology, pathophysiology and treatment.

  2013cited by this paper
• Platelet activating factors in depression and coronary artery disease: a potential biomarker related to inflammatory mechanisms and neurodegeneration.

  2013cited by this paper
• Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes

  2012cited by this paper
• Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis

  2012cited by this paper
• Mitochondria, oxidative stress and neurodegeneration.

  2012cited by this paper
• Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients

  2012cited by this paper
• Depression: an inflammatory illness?

  2012cited by this paper
• Chronic mild stress damages mitochondrial ultrastructure and function in mouse brain.

  2011cited by this paper
• The role of proteomics in depression research

  2009cited by this paper
• The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

  2009cited by this paper
• Inflammatory markers in depression

  2009cited by this paper
• Mitochondria and Energetic Depression in Cell Pathophysiology

  2009cited by this paper
• Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression.

  2009cited by this paper
• Mitochondrial involvement in psychiatric disorders

  2008cited by this paper
• Neuroanatomical Pattern of Mitochondrial Complex I Pathology Varies between Schizophrenia, Bipolar Disorder and Major Depression

  2008cited by this paper

• Role of mitochondrial dysfunction in muscle wasting in cancer cachexia: a narrative review.

  2026cites this paper
• Depressive Symptoms and Risk of Hearing Loss Among Adults Aged 55 Years and Older: A Population-Based Study

  2025cites this paper
• The relationship between antioxidant vitamins and mental disorders: a meta-analysis.

  2025cites this paper
• Mesenchymal Stem Cells Pretreated with Lactobacillus plantarum Supernatant Attenuate Depressive ‐ like Behavior via Inhibition of NLRP3 ‐ Mediated Neuroinflammation: An Ex Vivo, In Vivo, and In Silico Studies

  year unknowncites this paper